Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

0.9797
-0.1203-10.94%
Post-market: 0.9776-0.0021-0.21%19:55 EDT
Volume:7.94M
Turnover:8.13M
Market Cap:61.69M
PE:-0.82
High:1.12
Open:1.12
Low:0.9433
Close:1.10
52wk High:3.82
52wk Low:0.9433
Shares:62.96M
Float Shares:21.58M
Volume Ratio:0.23
T/O Rate:36.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:2.30
PE(LYR):-0.98

Loading ...

OverviewCompanyNewsFilings

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 12

Simcere says China regulator accepts NDA for atopic dermatitis drug rademikibart

Reuters
·
Apr 30

Northland Securities Remains a Buy on Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 24

Connect Biopharma Holdings Ltd - Expects to Report Phase 2 Seabreeze Stat Topline Data in Mid-2026

THOMSON REUTERS
·
Apr 23

Connect Biopharma Holdings: Data Monitoring Committee Reports No Safety Concerns or Treatment-Related Serious Adverse Events in Seabreeze Stat Studies

THOMSON REUTERS
·
Apr 23

Connect Biopharma Holdings - Enrollment in Phase 2 Seabreeze Stat Studies Will Continue as Planned Following Pre-Specified Interim Analysis

THOMSON REUTERS
·
Apr 23

Connect Biopharma Seabreeze STAT Phase 2 trials continue unchanged after interim review

Reuters
·
Apr 23

Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 08

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 12, 2026 Post-Mkt
Financial Report Announcement
May 12, 2026 Pre-MKt
Financial Report Announcement
Mar 31, 2026 Post-Mkt
Financial Report Announcement
Nov 12, 2025 Pre-MKt
Financial Report Announcement
Aug 13, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.82
Current
-1.64
Sector Average
58.52%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.82
Maximum
-0.18
+1 STD
-0.40
Minimum
-7.59
-1 STD
-2.87
Average
-1.64

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.